Search

everythinglearnresearchcommunity

for

Search:↓

CG2001 is safe, well-tolerated, and a promising treatment for hair loss with fewer side effects.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

Minoxidil can cause lung disease that looks like hypersensitivity pneumonitis.

A new mutation, Glu402Lys, in hair keratin is linked to variable symptoms of monilethrix.

Low-dose flutamide effectively maintains reduced hirsutism with no side effects.

The device effectively and safely increased hair growth in people with Androgenetic Alopecia.

CG2001 is safe and well-tolerated for treating hair loss in men.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

The herbal hair gel could be a safe hair growth treatment with minimal side effects.

Tgm2 helps stabilize dying cells and aids fibroblast attachment to the extracellular matrix.

High-dose oral minoxidil can improve hair growth but may cause side effects.

Analyzing hair with this method can help understand and monitor scalp conditions and treatment effects.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

IMSG nanoparticles improve vaccine delivery and immune response through hair follicles.

MPZL3 protein helps keep sebaceous gland size and cell growth in check.

A new mutation in the hHb1 keratin gene is linked to the hair disorder monilethrix.

A witch-hazel-based 5% minoxidil solution is effective and safe for women with hair loss who didn't respond to regular minoxidil, especially if they're sensitive to propylene glycol.

Combining minoxidil with ginsenoside Rg3 and glycyrrhizic acid offers a more effective treatment for androgenic alopecia.

Topical GT20029 effectively promotes hair regrowth and is well-tolerated.

Testosterone therapy can improve hormone levels and quality of life in men with morphine-induced hormone issues.

Combining growth factors with minoxidil improves hair growth more than minoxidil alone.

Optimizing the method improved minoxidil measurement accuracy and efficiency.

A rare genetic disorder causes sparse hair and vision loss due to a CDH3 gene mutation.

MRI helps evaluate androgenetic alopecia severity.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

ENERGI-F701 solution was found to be more effective and safer than Regaine® 2% minoxidil solution in treating female pattern hair loss, with increased hair density and less side effects.

Injecting alpha-melanocyte-stimulating hormone in mice improved skin healing and reduced scarring.

Feminizing hormone therapy increases hair counts and improves hair-related quality of life, while masculinizing therapy may reduce large terminal hairs.

A woman developed male characteristics after using unregulated hormone therapy.

Hirsutism significantly lowers the quality of life for Turkish women.